 SEATTLE, Jan. 04, 2022 GLOBE NEWSWIRE -- Chinook Therapeutics, Inc. NASDAQ: KDNY, a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in the following upcoming virtual investor conferences: 